© Rosalind Scientific LLC 2018-2022
© Rosalind Scientific LLC, 2018-2022
New Drug Hunter content, featured events and job postings straight to your inbox. Trusted by >3,500 drug hunters worldwide, unsubscribe anytime.
<< Back to July
>1000x BD2-selective BET bromodomain inh.
orally available in dog
rational design from prior lead
Journal of Medicinal Chemistry
GlaxoSmithKline, Stevenage, UK
The GSK BET BD2 inhibitor, GSK852, is one of a series of BD2-targeting compounds published last month by GSK (see a fragment-based approach here, a DEL screening approach here, and a pincolinamide…
Ask your company or librarian about a Drug Hunter membership to to see all summaries and get access to even more helpful information.